ResearcherSaitama Medical UniversityActive in the last 2 years
Akifumi Kimura
Matched on ORCID iD 0000-0003-2445-2557; OpenAlex author ID A5051247382. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 48
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 5
- Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study. Co-author DOI 10.1007/s00535-026-02432-2↗
- Prognostic impact of dose reduced S-1 adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: a retrospective multicenter study. Co-author DOI 10.1007/s10147-025-02742-0↗
- Predicting conversion surgery in patients with locally advanced pancreatic cancer after modified FOLFIRINOX treatment. Co-author DOI 10.1016/j.asjsur.2023.03.162↗
- Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer. Co-author DOI 10.1097/md.0000000000014369↗
- Importance of maintaining left gastric arterial flow at Appleby operation preserving whole stomach for central pancreatic cancer. Co-author DOI 10.5754/hge12164↗
Closest collaborators
The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshifumi Beck · 2 shared papers, 2023–2025 · strength 0.41
- Paper Prognostic impact of dose reduced S-1 adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: a retros… DOI 10.1007/s10147-025-02742-0↗
- Paper Predicting conversion surgery in patients with locally advanced pancreatic cancer after modified FOLFIRINOX treatment. DOI 10.1016/j.asjsur.2023.03.162↗
- Makoto Nishikawa · 3 shared papers, 2012–2025 · strength 0.34
- Paper Prognostic impact of dose reduced S-1 adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: a retros… DOI 10.1007/s10147-025-02742-0↗
- Paper Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer. DOI 10.1097/md.0000000000014369↗
- Paper Importance of maintaining left gastric arterial flow at Appleby operation preserving whole stomach for central pancreat… DOI 10.5754/hge12164↗
- Takahiro Einama · 2 shared papers, 2019–2025 · strength 0.31
- Paper Prognostic impact of dose reduced S-1 adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: a retros… DOI 10.1007/s10147-025-02742-0↗
- Paper Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer. DOI 10.1097/md.0000000000014369↗
- Yoji Kishi · 1 shared paper, 2025 · strength 0.22
- Yoichi Miyata · 1 shared paper, 2025 · strength 0.22
- Kazuki Kobayashi · 1 shared paper, 2025 · strength 0.22
- Ryota Kogure · 1 shared paper, 2023 · strength 0.19
- Masahiko Komagome · 1 shared paper, 2023 · strength 0.19
- Satoru Abe · 1 shared paper, 2023 · strength 0.19
- Riki Ninomiya · 1 shared paper, 2023 · strength 0.19
- Hideki Motobayashi · 1 shared paper, 2026 · strength 0.18
- Joe Matsumoto · 1 shared paper, 2026 · strength 0.18
- Yosuke Inoue · 1 shared paper, 2026 · strength 0.18
- Masaaki Murakawa · 1 shared paper, 2026 · strength 0.18
- Sohei Satoi · 1 shared paper, 2026 · strength 0.18
- Masamichi Hayashi · 1 shared paper, 2026 · strength 0.18
- Aoi Hayasaki · 1 shared paper, 2026 · strength 0.18
- Takayoshi Nakajima · 1 shared paper, 2026 · strength 0.18
- Yoshitaro Shindo · 1 shared paper, 2026 · strength 0.18
- Masafumi Imamura · 1 shared paper, 2026 · strength 0.18
- Keiko Kamei · 1 shared paper, 2026 · strength 0.18
- Kenjiro Okada · 1 shared paper, 2026 · strength 0.18
- Tsukasa Ikeura · 1 shared paper, 2026 · strength 0.18
- Keinosuke Ishido · 1 shared paper, 2026 · strength 0.18
- Tatsunori Suzuki · 1 shared paper, 2026 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.